Summary: Donation of CCP, Blood Components and HCT/Ps, Including Information on COVID-19 Vaccines or Treatment with CCP or Monoclonals (updated 04/14/21)
This section contains information on questionnaires used to screen prospective donors and help ensure the safety of the donation process as well as the product being donated. AABB has played a leadership role in the development of model questionnaires for blood collection facilities as well as for facilities involved in the collection of hematopoietic progenitor cells (HPCs).
New Zealand’s Medsafe Approves Individual Donor Assessment
February 04, 2025
REGULATORY UPDATE: FDA Draft Guidance Proposes Selective Donor Testing Strategy for Malaria Risk
January 15, 2025
Honduras, Luxembourg Take Steps to Expand Donor Eligibility
December 10, 2024
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
